Inflammatory Bowel Disease Associates with Proinflammatory Potential of the Immunoglobulin G Glycome

Abstract

The observed differences indicate significantly increased inflammatory potential of IgG in IBD. Changes in IgG glycosylation may contribute to IBD pathogenesis and could alter monoclonal antibody therapeutic efficacy. IgG glycan profiles have translational potential as IBD biomarkers.